Skip to main content

Table 1 Patient and disease characteristics of 46 patients with paranasal sinus carcinomas treated with IMRT

From: Intensity modulated radiotherapy (IMRT) in patients with carcinomas of the paranasal sinuses: clinical benefit for complex shaped target volumes

 

N (%)

Gender

 

female

18 (39%)

male

28 (61%)

Histology

 

Adenocarcinoma

8 (17.4%)

Squamous Cell Carcinoma

6 (13%)

Adenoid-cystic Carcinoma

20 (43.4%)

Melanoma

8 (17.4%)

other

4 (8.8%)

Primary tumor site

 

Maxillary sinus

22 (47.8%)

Ethmoidal sinus

4 (8.7%)

Sphenoid sinus

4 (8.7%)

Nasal cavity

16 (34.8%)

Tumor stage

 

T1

2 (4%)

T2

3 (7%)

T3

11 (24%)

T4

30 (65%)

Nodal stage

 

N0

34 (74%)

N1

6 (13%)

N2

1 (2%)

Nx

5 (11%)